Together with these data, EREG plays a crucial role in the progression of EGFR-positive HCC, meaning that targeting EREG therapy may contribute to developing a novel, tailor-made therapeutic strategy against HCC in the future. Here, EGFR is linked to hepatocellular carcinoma.